Overview
- ITIA confirmed Bagnis elected a voluntary provisional suspension on October 18 under the Tennis Anti-Doping Programme, with time served credited against any future sanction.
- The A sample from an August 18 in-competition test during US Open qualifying detected hydrochlorothiazide, a WADA-prohibited diuretic classified as a Specified substance.
- He did not hold a therapeutic use exemption and received a pre-charge notice of an Anti-Doping Rule Violation on October 2.
- Bagnis has stated he never knowingly used a banned substance, is cooperating with the investigation, and has suggested possible cross-contamination in a public statement.
- During the provisional suspension he is barred from competing, coaching, or attending events sanctioned by the ATP, WTA, ITF, or the Grand Slams while the process continues.